Synthesis, in silico and in vitro Evaluation of Novel Oxazolopyrimidines as Promising Anticancer Agents

被引:13
作者
Velihina, Yevheniia [1 ,2 ]
Scattolin, Thomas [3 ]
Bondar, Denys [1 ]
Pil'o, Stepan [2 ]
Obernikhina, Nataliya [4 ]
Kachkovskyi, Olesksiy [2 ]
Semenyuta, Ivan [2 ]
Caligiuri, Isabella [5 ]
Rizzolio, Flavio [5 ,6 ]
Brovarets, Volodymyr [2 ]
Karpichev, Yevgen [1 ]
Nolan, Steven P. [3 ]
机构
[1] Tallinn Univ Technol, Sch Sci, Dept Chem & Biotechnol, Akad Tee 15, EE-12618 Tallinn, Estonia
[2] Natl Acad Sci Ukraine, VP Kukhar Inst Bioorgan Chem & Petrochem, Murmanska Str 1, UA-02094 Kiev 94, Ukraine
[3] Univ Ghent, Dept Chem, Krijgslaan 281, BE-9000 Ghent, Belgium
[4] OO Bogomolets Natl Med Univ, T Shevchenko Blvd 13, UA-01601 Kiev, Ukraine
[5] Ctr Riferimento Oncol Aviano CRO IRCCS, Dept Mol Biol & Translat Res, Pathol Unit, Via Franco Gallini 2, IT-33081 Aviano, Italy
[6] Univ Ca Foscari, Dept Mol Sci & Nanosyst, Campus Sci,Via Torino 155, IT-30174 Venice, Italy
关键词
antitumor agents; donor-acceptor systems; molecular docking; oxazolopyrimidines; Suzuki-Miyaura reaction; ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE; INHIBITORS; DISCOVERY; VEGF; ANGIOGENESIS; OPTIMIZATION; DIAGNOSIS; DOCKING; DESIGN;
D O I
10.1002/hlca.202000169
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
New potential bioactive oxazolopyrimidines have been synthesized using two main approaches: the pyrimidine ring annulation on a functionalized oxazole and the benzoyl bromide trimerization followed by rearrangement and formation of the oxazolo[5,4-d]pyrimidine scaffold. The docking analyzes have shown that 7-piperazine substituted oxazolo[4,5-d]pyrimidines 8a-8c could be potential VEGFR2 inhibitors with high free energy of ligand-protein complex formation (Delta G: -10.1, -9.6, -9.8 kcal/mol, respectively). In vitro antitumor assays confirmed theoretical predictions that oxazolo[4,5-d]pyrimidines 8a-8c containing positively charged piperazine moiety should demonstrate significantly higher cytotoxic effects. 4-[5-(4-Chlorophenyl)-2-phenyl[1,3]oxazolo[4,5-d]pyrimidin-7-yl]piperazin-1-ium trifluoroacetate (8c) exhibited a slightly higher antiproliferative effect (IC50=0.21 mu m) than doxorubicin (IC50=0.36 mu m) on MDA-MB-231 cell line and has relatively good results on OVCAR-3 (IC50=1.7 mu m) and HCT-116 (IC50=0.24 mu m) cells.
引用
收藏
页数:14
相关论文
共 39 条
[11]   Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy [J].
Dvorak, HF .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4368-4380
[12]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[13]   Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J].
Ferrara, N ;
Hillan, KJ ;
Gerber, HP ;
Novotny, W .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :391-400
[14]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[15]   VEGF targets the tumour cell [J].
Goel, Hira Lal ;
Mercurio, Arthur M. .
NATURE REVIEWS CANCER, 2013, 13 (12) :871-882
[16]   Avogadro: an advanced semantic chemical editor, visualization, and analysis platform [J].
Hanwell, Marcus D. ;
Curtis, Donald E. ;
Lonie, David C. ;
Vandermeersch, Tim ;
Zurek, Eva ;
Hutchison, Geoffrey R. .
JOURNAL OF CHEMINFORMATICS, 2012, 4
[17]   Estimation of biological affinity of nitrogen-containing conjugated heterocyclic pharmacophores [J].
Kachaeva, Marina V. ;
Obernikhina, Nataliya V. ;
Veligina, Evgenia S. ;
Zhuravlova, Maryna Yu. ;
Prostota, Yaroslav O. ;
Kachkovsky, Oleksiy D. ;
Brovarets, Volodymyr S. .
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2019, 55 (4-5) :448-454
[18]   Synthesis, characterization, and in vitro anticancer evaluation of 2-substituted 5-arylsulfonyl-1,3-oxazole-4-carbonitriles [J].
Kachaeva, Maryna V. ;
Pilyo, Stepan G. ;
Zhirnov, Victor V. ;
Brovarets, Volodymyr S. .
MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (01) :71-80
[19]   EXPRESSION OF THE FMS-LIKE TYROSINE KINASE-4 GENE BECOMES RESTRICTED TO LYMPHATIC ENDOTHELIUM DURING DEVELOPMENT [J].
KAIPAINEN, A ;
KORHONEN, J ;
MUSTONEN, T ;
VANHINSBERGH, VWM ;
FANG, GH ;
DUMONT, D ;
BREITMAN, M ;
ALITALO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3566-3570
[20]   Focused screening to identify new adenosine kinase inhibitors [J].
Koese, Meryem ;
Schiedel, Anke C. ;
Bauer, Alexander Andreas ;
Poschenrieder, Hermann ;
Burbiel, Joachim C. ;
Akkinepally, Raghuram Rao ;
Stachef, Hans-Dietrich ;
Mueller, Christa E. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) :5127-5133